Current state of play regarding dental extractions in patients with haemophilia: Consensus or evidence-based practice? A review of the literature.
haemophilia
inherited blood coagulation disorders
oral haemorrhage
oral surgery
surgical haemostasis
tooth extraction
Journal
Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
14
10
2019
revised:
17
12
2019
accepted:
03
01
2020
pubmed:
22
1
2020
medline:
3
11
2020
entrez:
22
1
2020
Statut:
ppublish
Résumé
Due to the global prevalence of oral disease, tooth extraction is the most common surgical procedure required in general population thus likely to be similarly common in patients with haemophilia, especially those in older age and those living in countries with restricted resources. There are little or no consensus about optimal level and duration of factor replacement (FRP) therapy required to prevent bleeding complication following surgery and low levels of evidence to inform protocols and guidelines. The goal of this article was to review the literature regarding haematological treatment protocols and to assess their effectiveness in prevention of bleeding complications during and after tooth extractions in people with haemophilia. A total number of 29 articles were identified. Only two of the studies were randomized controlled trials, and meta-analysis was not possible. Significant heterogeneity regarding haematological regimes, dental surgical procedures, disease severity and sample size of published studies which are unable to reliably inform the provision of safe dental surgery was noted. Based on the haematological regimens, all studies were classified into one of three groups: pre- and postoperative FRP or DDAVP, single preoperative FRP or DDAVP, and no FRP treatment. The overall reported bleeding rate in case of both pre- and postoperative FRP and single dose FRP preoperative is similar, 11.9% and 11.4%, respectively, indicating that minimizing the use of clotting factor concentrate is possible if proper local haemostatic measures are provided. Strictly designed prospective studies with higher number of patients are necessary to get firm conclusions about optimal FRP treatment required to prevent bleeding complications during and after oral surgery in patients with haemophilia.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
183-199Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Peres MA, Macpherson LMD, Weyant RJ, et al. Oral diseases: a global public health challenge. Lancet. 2019;394(10194):249-260.
Dougall A, Pani SC, Daly B, et al. The PROBE-Global burden of bleeding from the mouth in Haemophilia-a call to action. Haemophilia. 2018;24:66-67.
Hermans C, Altisent C, Batorova A, et al. Haemophilia Therapy Standardisation Board. Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations. Haemophilia. 2009;15:639-658.
Anderson JAM, Brewer A, Creagh D, et al. Guidance on the dental management of patients with haemophilia and congenital bleeding disorders. Br Dent J. 2013;215:497-504.
Brewer A, Correa ME. Guidelines for dental treatment of patients with inherited bleeding disorders. World Federation of Hemophilia Treatment of Hemophilia Monograph, 2006. Available from: http://www1.wfh.org/publications/files/pdf-1190.pdf. Accessed May 8, 2019.
Brewer A. Dental management of patients with inhibitors to factor VIII or factor IX. World Federation of Hemophilia Treatment of Hemophilia Monograph, 2008. Available from: http://www1.wfh.org/publications/files/pdf-1200.pdf. Accessed May 8, 2019.
Scully C, Diz Dios P, Giangrande P. Oral care for people with hemophilia or a hereditary bleeding tendency. World Federation of Hemophilia Treatment of Hemophilia Monograph, 2008. Available from: http://www1.wfh.org/publications/files/pdf-1164.pdf. Accessed August 8, 2017.
Hewson ID, Daly J, Hallett KB, et al. Consensus statement by hospital based dentists providing dental treatment for patients with inherited bleeding disorders. Aust Dent J. 2011;56:221-226.
Hewson I, Makhmalbaf P, Street A, Mccarthy P, Walsh M. Dental surgery with minimal factor support in the inherited bleeding disorder population at the Alfred Hospital. Haemophilia. 2011;17(1):e185-e188.
Dougall A, Apperley O, Smith G, Madden L, Parkinson L, Daly B. Safety of buccal infiltration local anaesthesia for dental procedures. Haemophilia. 2019;25(2):270-275.
Cocero N, Pucci F, Messina M, Pollio B, Mozzati M, Bergamasco L. Autologous plasma rich in growth factors in the prevention of severe bleeding after teeth extractions in patients with bleeding disorders: a controlled comparison with fibrin glue. Blood Transfus. 2015;13:287-294.
Goldmann G, Berens C, Marquardt N, Reich R, Oldenburg J, Wenghoefer M. No increased bleeding risk for oral surgery in patients with severe congenital bleeding disorders due to intense perioperative management. Oral Maxillofac Surg. 2015;19:195-200.
Hsieh JT, Klein K, Batstone M. Ten-year study of postoperative complications following dental extractions in patients with inherited bleeding disorders. Int J Oral Maxillofac Surg. 2017;46(9):1147-1150.
Peisker A, Raschke GF, Schultze-Mosgau S. Management of dental extraction in patients with hemophilia A and B: a report of 58 extractions. Med Oral Patol Oral Cir Bucal. 2014;19(1):e55-60.
Ramstrom G, Blomback M. Tooth extractions in hemophiliacs. Int J Oral Surg. 1975;4:1-17.
Sindet-Pedersen S, Stenbjerg S. Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery. J Oral Maxillofac Surg. 1986;44:703-707.
Piot B, Sigaud-Fiks M, Huet P, Fressinaud E, Trossaert M, Mercier J. Management of dental extractions in patients with bleeding disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:247-250.
Walsh PN, Rizza CR, Matthews JM, et al. Epsilon- Aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double blind controlled trial. Br J Haematol. 1971;20:463-475.
Mariana G, Ciavarella N, Mazzucconi MG, et al. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in hemophilia and von Willebrand's disease. A study on 43 patients. Clin Lab Haematol. 1984;6(3):229-238.
Saulnier J, Marey A, Horellou M-H, et al. Evaluation of desmopressin for dental extractions in patients with hemostatic disorders. Oral Surg Oral Med Oral Pathol. 1994;77:6-12.
Biggs R, Rush BM, Macfarlane RG, Matthews JM, Johnstone FC,Hayton-Williams DS. Further experience in use of human antihaemophilic globulin (H.A.H.G.) for the control of bleeding after dental extraction in haemophilic patients: a report of the Medical Research Council's working party on human antihaemophilic globulin. Lancet. 1965;17:969-974.
Franchini M, Rossetti G, Tagliaferri A, et al. Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers. Haemophilia. 2005;11:504-509.
Frachon X, Pommereuil M, Berthier A-M, et al. Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000-2002). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:270-275.
Givol N, Hirschhorn A, Lubetsky A, Bashari D, Kenet G. Oral surgery-associated postoperative bleeding in haemophilia patients - a tertiary centre's two decade experience. Haemophilia. 2015;21:234-240.
Zanon E, Martinelli F, Bacci C, Zerbinati P, Girolami A. Proposal of a standard approach to dental extraction in hemophilia patients. A case control study with good results. Haemophilia. 2000;6:533-536.
Ramstrom G, Blomback M, Egberg N, Johnsson H, Ljungberg B, Schulman S. Oral surgery in patients with hereditary bleeding disorders. A survey of treatment in the Stockholm area (1974-1985). Int J Oral Maxillofac Surg. 1989;18:320-322.
Stajcic Z. The combined local/systemic use of antifibrinolytics in hemophiliacs undergoing dental extractions. Int J Oral Surg. 1985;14:339-345.
Björlin G. Local fibrinolysis in the oral cavity. Scan J Haematol. 1984;33(Suppl 40):411-416.
Forbes CD, Barr RD, Reid G, et al. Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. Br Med J. 1972;2:311-313.
Stajčić Z, Baklaja R, Elezović I, Rolović Z. Primary wound closure in hemophiliacs undergoing dental extractions. Int J Oral Maxillofac Surg. 1989;18:14-16.
Vinckier F, Vermylen J. Dental extractions in hemophilia: reflections on 10 years' experience. Oral Surg Oral Med Oral Pathol. 1985;59(1):6-9.
Scully C, Watt-Smith P, Dios PD, Giangrande PLF. Complications in HIV-infected and non-HIV-infected haemophiliacs and other patients after oral surgery. Int J Oral Maxillofac Surg. 2002;31:634-640.
Baudo F, de Cataldo F, Gatti R, Landonio G, Muti G, Scolari G. Local Hemostasis after tooth extraction in patients with abnormal hemostatic function. Haemostasis. 1985;15:402-404.
Baudo F, deCataldo F, Landonio G, Muti G. Management of oral bleeding in haemophilic patients. Lancet. 1988;2:1082.
Correa MEP, Annicchino-Bizzacchi JM, Jorge J, et al. Clinical impact of oral health indexes in dental extraction of hemophilic patients. J Oral Maxillofac Surg. 2006;64(5):785-788.
Lewandowski B, Wojnar J, Brodowski R, Mucha M, Czenczek-Lewandowska E, Brzecka D. Dental extractions in patients with mild hemophilia A and hemophilia B and von Willebrand disease without clotting factor supplementation. Pol Arch Intern Med. 2018;128:7-8.
Rakocz M, Mazar A, Varon D, et al. Dental extractions in patients with bleeding disorders. The use of fibrin glue. Oral Surg Oral Med Oral Pathol. 1993;75(3):280-282.
Tavenner RWH. Use of tranexamic acid in control of haemorrhage after extraction of teeth in haemophilia and Christmas disease. Br Med J. 1972;2:314-315.
Rahman A, Nizarali N, Dougall A, Daly BUK. hemophilia treaters’ knowledge of risk assessment for prolonged bleeding associated with dental procedures. Spec Care Dentist. 2019;39(2):173-179.
Rasaratnam L, Chowdary P, Pollard D, Subel B, Harrington C, Darbar UR. Risk-based management of dental procedures in patients with inherited bleeding disorders: Development of a Dental Bleeding Risk Assessment and Treatment Tool (DeBRATT). Haemophilia. 2017;23:247-254.
Mancuso ME, Santagostino E. Dental surgery in inherited bleeding disorders with minimal factor support: commentary. Haemophilia. 2011;17:e183-e184.
Sindet-Pedersen S, Gram J, Jespersen J. Characterization of plasminogen activators in unstimulated and stimulated human whole saliva. J Dent Res. 1987;66:1199-1203.
Gersel-Pedersen N. Fibrinolytic activity of blood and saliva before and after oral surgery. Int J Oral Surg. 1981;10(Suppl 1):114-121.
Majerus P, Dalcette B, Hermans M, Pourtois M, Capel P. Variations in fibrinolytic activity of human whole saliva. Eur J Oral Sci. 1996;104:341-345.
Sindet-Pedersen S. Distribution of tranexamic acid to plasma and saliva after oral administration and mouth rinsing: a pharmacokinetic study. J Clin Pharmacol. 1987;27:1005-1008.
van Galen KPM, Engelen ET, Mauser-Bunschoten EP, van Es RJJ, Schutgens REG. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or von Willebrand disease undergoing minor oral surgery or dental extractions (Review). Cochrane Database Syst Rev. 2015;12:CD011385.
Coppola A, Windyga J, Tufano A, Yeung C, Di Minno MND. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery (Review). Cochrane Database Syst Rev. 2015;2:CD009961.
Bajkin BV, Selakovic SD, Mirkovic SM, Sarcev IN, Tadic AJ, Milekic BR. Comparison of efficacy of local hemostatic modalities in anticoagulated patients undergoing tooth extractions. Vojnosanit Pregl. 2014;71(12):1097-1101.
Carter G, Goss A, Lloyd J, Tocchetti R. Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study. J Oral Maxillofac Surg. 2003;61(12):1432-1435.
Blinder D, Manor Y, Martinowitz U, Taicher S, Hashomer T. Dental extractions in patients maintained on continued oral anticoagulant: comparison of local hemostatic modalities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(2):137-140.
Halfpenny W, Fraser JS, Adlam DM. Comparison of 2 hemostatic agents for the prevention of postextraction hemorrhage in patients on anticoagulants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92(3):257-259.
Rodriguez-Merchan EC. Fibrin glue for local haemostasis in haemophilia surgery. Hosp Pract. 2017;45(5):187-191.
Bajkin BV, Rajic NV, Vujkov SB. Dental extraction in a hemophilia patient without factor replacement therapy: a case report. J Oral Maxillofac Surg. 2012;70:2276-2277.
Windyga J, Stefanska-Windyga E, Odnoczko E, Baran B, Czubak G. Activated prothrombin complex concentrate in combination with tranexamic acid: a single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitors. Haemophilia. 2016;22:e465-e468.
Laguna P, Klukowska A. Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor. Haemophilia. 2005;11:2-4.
Zanon E, Brandolin B, Saggiorato G, Bacci C. Complex dental extractions in a patient with severe haemophilia A and inhibitors treated with activated prothrombin complex concentrate. Blood Tranfus. 2012;10:225-227.
Heiland M, Weber M, Schmelzle R. Life-threatening bleeding after dental extraction in a hemophilia A patient with inhibitors to factor VIII: a case report. J Oral Maxillofac Surg. 2003;61:1350-1353.
Franchini M, Marano G, Pati I, et al. Emicizumab for the treatment of haemophilia A: a narrative review. Blood Transfus. 2019;17(3):223-228.
Susen S, Gruel Y, Godier A, et al. Management of Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra®): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP). Haemophilia. 2019;25:731-737.